Table 2.
Logistic regression results showing odds and adjusted* odds ratios of skin manifestations in patients who had successful versus non-successful weight loss post bariatric surgery
| Univariate | Adjusted | |||||
|---|---|---|---|---|---|---|
| Skin manifestations | Non-successful weight loss patients (N = 24) | Successful weight loss patients (N = 46) | OR (95%CI) | p-value* | Adjusted OR (95%CI)a | Adjusted p-value* |
| Hair | ||||||
| Alopecia (%) | 10 (41.67%) | 31 (67.39%) | 2.89 (1.04,8.02) | 0.04* | 2.75 (0.88, 8.57) | 0.08 |
| Skin | ||||||
| Psoriasis (%) | 0 (0%) | 2 (4.35%) | 1 (−) | – | – | – |
| Diagonal earlobe creases (%) | 1 (4.17%) | 1 (2.17%) | 0.51 (0.03, 8.55) | 0.64 | – | – |
| Acanthosis nigricans (%) | 15 (62.5%) | 19 (41.3%) | 0.42 (0.15, 1.16) | 0.10 | – | – |
| AN-neck (%) | 15 (62.5%) | 17 (36.96%) | 0.35 (0.13,0.98) | 0.045* | 0.33 (0.09, 1.17) | 0.09 |
| AN-axillae (%) | 11 (45.83%) | 9 (19.57%) | 0.29 (0.1, 0.85) | 0.03* | 0.37 (0.11, 1.27) | 0.11 |
| AN-antecubital fossa (%) | 2 (8.33%) | 2 (4.35%) | 0.5 (0.07, 3.79) | 0.50 | – | – |
| AN-inguinal areas (%) | 6 (25%) | 3 (6.52%) | 0.21 (0.05, 0.93) | 0.04* | 0.21 (0.04,1.21) | 0.08 |
| AN-inframammary areas (%) | 1 (4.17%) | 0 (0%) | 1 (−) | – | – | – |
| Acrochordons/skin tags (%) | 11 (45.83%) | 24 (52.17%) | 1.29 (0.48, 3.47) | 0.62 | – | – |
| Acrochordons/skin tags -neck (%) | 8 (33.33%) | 22 (47.83%) | 1.83 (0.66, 5.12) | 0.25 | – | – |
| Acrochordons/skin tags-axillae (%) | 3 (12.5%) | 9 (19.57%) | 1.7 (0.41, 6.99) | 0.46 | ||
| Acrochordons/skin tags-inguinal areas (%) | 0 (0%) | 2 (4.35%) | – | – | – | – |
| Acrochordons/skin tags-eyelid (%) | 1 (4.17%) | 1 (2.17%) | 0.51 (0.03, 8.55) | 0.64 | – | – |
| Acrochordons/skin tags-trunk (%) | 5 (20.83%) | 6 (13.04%) | 0.57 (0.15,2.10) | 0.40 | – | – |
| Acrochordons/skin tags-inframammary areas (%) | 1 (4.17%) | 0 (0%) | 1 (−) | – | – | – |
| KP (%) | 14 (58.33%) | 12 (26.09%) | 0.25 (0.09, 0.72) | 0.01* | 0.21 (0.06, 0.74) | 0.02* |
| Pebble fingers (%) | 5 (20.83%) | 1 (2.17%) | 0.08 (0.01, 0.77) | 0.03* | 0.09 (0.01, 0.89) | 0.04* |
| Striae distensae (%) | 16 (66.67%) | 27 (58.7%) | 0.71 (0.25, 1.99) | 0.52 | – | – |
| Folliculitis (%) | 2 (8.33%) | 2 (4.35%) | 0.5 (0.07, 3.8) | 0.50 | – | – |
| Intertrigo (%) | 7 (29.17%) | 12 (26.09%) | 0.86 (0.29, 2.57) | 0.78 | – | – |
| Chronic venous disease manifestations (%) | 9 (37.5%) | 11 (23.91%) | 0.52 (0.18, 1.52) | 0.24 | – | – |
| Plantar hyperkeratosis (%) | 19 (79.17%) | 27 (58.70%) | 0.37 (0.12, 1.18) | 0.09 | – | – |
AN acanthosis nigricans, KP keratosis pilaris
*p < 0.05
a Adjusted for age, sex, and underlying diseases (i.e. hypertension, dyslipidemia, diabetes mellitus, and polycystic ovarian syndrome)